Print Page  Close Window

Investors

OraSure Technologies develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians’ offices, and commercial and industrial entities.
More>>
Featured Reports
Fact Sheet - PDF Fact Sheet
2018 Annual Report on Form 10-K - PDF 2018 Annual Report on Form 10-K
OSUR (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$8.45
Change (%) Stock is Down 0.08 (0.94%)
Volume45,414
Data as of 05/20/19 10:27 a.m. ET
Minimum 20 minute delay
Refresh quote
Recent NewsMore >>
DateTitle 
05/15/19OraSure Technologies to Present at UBS Global Healthcare Conference
BETHLEHEM, Pa., May 15, 2019 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Dr. Stephen S. Tang, President and CEO, will speak to the investment community at the UBS Global Healthcare Conference.  The conference will be simultaneously webcast over the Internet. Dr. Tang is scheduled to speak on Wednesday, May 22, 2019, at approximately 9:30 AM Eastern Time (6:30 AM Pacific Time).... 
Printer Friendly Version
05/14/19OraSure Technologies to Hold Virtual Annual Meeting of Stockholders on May 21, 2019
BETHLEHEM, Pa., May 14, 2019 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), announced that its 2019 Annual Meeting of Stockholders will be a completely virtual meeting, conducted as a live webcast beginning at 10:00 a.m. EDT (7:00 a.m. PDT) on Tuesday, May 21, 2019. In order to access the meeting, a stockholder or a person holding a valid stockholder proxy may go to www.virtualshareholdermeeting.com/OSUR2019 five (5) minutes prior to the start of the meeting to log in.  A st... 
Printer Friendly Version
05/08/19OraSure Announces 2019 First Quarter Financial Results
BETHLEHEM, Pa., May 08, 2019 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today announced its financial results for the quarter ended March 31, 2019. “Our first quarter 2019 performance was in line with our expectations for both the top and bottom lines,” said Stephen S. Tang, Ph.D., President and CEO of OraSure Technologies. “We are optimistic about the second quarter and full-year performance of ... 
Printer Friendly Version
04/17/19OraSure Technologies Earnings Conference Call Invitation
2019 First Quarter Earnings Conference Call Wednesday, May 8, 2019, 5:00 p.m. ET BETHLEHEM, Pa., April 17, 2019 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2019 first quarter financial results, updated financial guidance and certain business developments for 5:00 pm ET (2:00 pm PT) on Wednesday, May 8, 2019.  May 8, 2019 Schedule         4:01 p.m. ET 2019 ... 
Printer Friendly Version
Upcoming EventsMore >>
DateTitle
05/21/19 10:00 a.m. ET
OraSure Technologies, Inc. 2019 Annual Meeting of Stockholders
05/22/19 9:30 a.m. ET
OraSure Technologies, Inc. at the UBS Global Healthcare Conference
Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources